Susquehanna Initiates Coverage on Targanta Therapeutics (TARG) with a Neutral
Tweet Send to a Friend
Susquehanna initiates coverage on Targanta Therapeutics (Nasdaq: TARG) with a Neutral.
Susquehanna analyst says, "Targanta Therapeutics is a pure-play ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Susquehanna analyst says, "Targanta Therapeutics is a pure-play ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
